Immunome Inc (IMNM)
12.74
-0.08
(-0.59%)
USD |
NASDAQ |
Nov 05, 11:47
Immunome Profit Margin (Quarterly): -1.53K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.53K% |
| March 31, 2024 | -12.58K% |
| December 31, 2023 | -2.42K% |
| Date | Value |
|---|---|
| September 30, 2023 | -121.9% |
| June 30, 2023 | -130.4% |
| March 31, 2023 | -180.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.58K%
Minimum
Mar 2024
-121.9%
Maximum
Sep 2023
-2.83K%
Average
-854.3%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Protalix BioTherapeutics Inc | -16.35% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -194.6% |
| Return on Assets | -146.0% |
| Return on Invested Capital | -194.6% |
| Operating Margin (Quarterly) | -1.43K% |
| Return on Net Operating Assets | -5.23K% |